FEMASYS INC(FEMY)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.3M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
FEMY Stock Analysis & AI Quality Score
AI stock analysis and institutional research for FEMASYS INC (FEMY), a Healthcare sector company. FEMY is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.3m in revenue. Based on the latest XBRL financial filings (Q1 2026), FEMASYS INC reports quarterly revenue of $424.9K, net income of $846.1K, free cash flow of $-4.2M. Top institutional holders of FEMY by reported 13-F value include Dauntless Investment Group,, GEODE CAPITAL MANAGEMENT,, BlackRock,, based on the most recent SEC filings. FEMY trades on the Nasdaq exchange and files with the SEC under CIK 1339005. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FEMY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FEMASYS INC directly from SEC EDGAR.
Revenue
Q1 2026
$424.9K
Net Income
Q1 2026
$846.1K
Free Cash Flow
Q1 2026
$-4.2M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+113.9% YoYNet Income
-30.7% YoYOperating Income
-21.2% YoYEPS (Diluted)
+49.5% YoYTotal Assets
-25.3% YoYOp. Cash Flow
-65.7% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Revenue | $2.3M +113.9% | $1.1M -11.1% | $1.2M +16.2% | $1.0M | — |
| Net Income | $-18.6M -30.7% | $-14.2M -25.0% | $-11.4M -64.8% | $-6.9M | — |
| Operating Income | $-17.6M -21.2% | $-14.5M -25.1% | $-11.6M -67.3% | $-6.9M | — |
| EPS (Diluted) | $-0.47 +49.5% | $-0.93 +3.1% | $-0.96 +86.7% | $-7.20 | — |
| Total Assets | $20.7M -25.3% | $27.8M +64.3% | $16.9M +122.1% | $7.6M | — |
| Operating Cash Flow | $-18.7M -65.7% | $-11.3M -5.1% | $-10.7M -117.6% | $-4.9M | — |
Get alerted when FEMY's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for FEMASYS INC including:
Top Institutional Holders of FEMY
Dauntless Investment Group, LLC
$2.5M6,033,030 shGEODE CAPITAL MANAGEMENT, LLC
$261.1K621,366 shBlackRock, Inc.
$75.0K178,501 shNORTHERN TRUST CORP
$49.8K118,411 shClear Creek Financial Management, LLC
$48.6K115,556 shEP Wealth Advisors, LLC
$42.0K100,000 shXTX Topco Ltd
$39.6K94,142 shSTATE STREET CORP
$34.0K80,869 shKovack Advisors, Inc.
$29.4K70,000 shCetera Investment Advisers
$26.1K62,000 sh
| Fund | Value | Shares |
|---|---|---|
| Dauntless Investment Group, LLC | $2.5M | 6,033,030 |
| GEODE CAPITAL MANAGEMENT, LLC | $261.1K | 621,366 |
| BlackRock, Inc. | $75.0K | 178,501 |
| NORTHERN TRUST CORP | $49.8K | 118,411 |
| Clear Creek Financial Management, LLC | $48.6K | 115,556 |
| EP Wealth Advisors, LLC | $42.0K | 100,000 |
| XTX Topco Ltd | $39.6K | 94,142 |
| STATE STREET CORP | $34.0K | 80,869 |
| Kovack Advisors, Inc. | $29.4K | 70,000 |
| Cetera Investment Advisers | $26.1K | 62,000 |
More Healthcare Companies
View all Healthcare →Put FEMY on your watchlist
Track score changes the day FEMASYS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is FEMY a good stock to buy?
13F Pro's AI-powered analysis of FEMASYS INC (FEMY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FEMY are available on the FEMY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own FEMY?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FEMY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FEMASYS INC's investment landscape.